Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AMAM | Ambrx Biopharma Cayman, Inc. | Director | $786K | May 18, 2023 | ||
AMAM | Ambrx Biopharma, Inc. | Director | $0 | Mar 7, 2024 | ||
PDSB | PDS Biotechnology Corp | Director | Jun 24, 2024 | |||
ZVSA | ZyVersa Therapeutics, Inc. | Chief Executive Officer, Director | May 24, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|